Ensign Peak Advisors’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Ensign Peak Advisors’s Portfolio FLACW Stock Details FLACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-150,000	Closed	-$126K	–	2335
2022 Q3	$126K	Hold	150,000	–	–	﹤0.01%	2032
2022 Q2	$13K	Hold	150,000	–	–	﹤0.01%	2142
2022 Q1	$35K	Hold	150,000	–	–	﹤0.01%	2155
2021 Q4	$86K	Buy	+150,000	New	+$105K	﹤0.01%	2089

Ensign Peak Advisors's FLACW Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 150,000 shares — an estimated $126K sold.

Ensign Peak Advisors first reported a position in FLACW in Q4 2021 and held it in 4 quarters. The position peaked at $126K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

Ensign Peak Advisors reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
Ensign Peak Advisors sold 150,000 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $126K.
Ensign Peak Advisors first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q4 2021 and held it in 4 quarters.
Ensign Peak Advisors's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $126K in Q3 2022.
0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.